World's Best Scientists 2026 revealed!
Ethan Rubinstein

Ethan Rubinstein

D-Index & Metrics

Microbiology

D-Index
75
Citations
19922
World Ranking
1501
National Ranking
47

Ethan Rubinstein publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Ethan Rubinstein sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 261 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Ethan Rubinstein D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Ethan Rubinstein sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 75 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Ethan Rubinstein was affiliated with the University of Manitoba in Canada. Their research primarily focused on various aspects of biochemistry, genetics, and molecular biology, with significant contributions to medicine. Rubinstein's work spanned multiple subfields including molecular biology, immunology and allergy, cell biology, and public health-related disciplines.

Their publications frequently explored topics such as extracellular vesicles in disease, cell adhesion molecules research, microRNA in disease regulation, caveolin-1 and cellular processes, RNA interference and gene delivery, as well as advanced biosensing and bioanalysis techniques.

Rubinstein contributed to several notable papers including:

  • Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9 (2021, Nature Communications)
  • Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles (2023, Journal of Extracellular Vesicles)
  • Tetraspanin-6 negatively regulates exosome production (2020, Proceedings of the National Academy of Sciences)
  • Lack of involvement of CD63 and CD9 tetraspanins in the extracellular vesicle content delivery process (2023, Communications Biology)
  • CD63 sorts cholesterol into endosomes for storage and distribution via exosomes (2024, Nature Cell Biology)

Their work was published in venues including bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, eLife, Nature Communications, and the Journal of Extracellular Vesicles.

Frequent collaborators included Roberta Palmulli, Clotilde Théry, Stéphanie Charrin, Nathalie Névo, and Frederik J. Verweij, who coauthored multiple papers with Rubinstein.

Rubinstein's research extensively covered mechanisms related to extracellular vesicles, cellular adhesion, and molecular signaling pathways, contributing data relevant to disease processes and molecular biology techniques.

Best Publications

  • Staphylococcus aureus Endocarditis A Consequence of Medical Progress

    Vance G. Fowler;Jose M. Miro;Bruno Hoen;Christopher H. Cabell

  • Comparative review of the carbapenems.

    George G Zhanel;Ryan Wiebe;Leanne Dilay;Kristjan Thomson

  • Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers.

    Arye Rubinstein;Marc Sicklick;Asha Gupta;Larry Bernstein

  • Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

    B J Kullberg;J D Sobel;M Ruhnke;P G Pappas

  • Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.

    Ethan Rubinstein;Sue K. Cammarata;Thomas H. Oliphant;Richard G. Wunderink

  • Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

    Javier Ariza;Mile Bosilkovski;Antonio Cascio;Juan D Colmenero

  • Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

    George G. Zhanel;George G. Zhanel;Christopher D. Lawson;Heather Adam;Heather Adam;Frank Schweizer

  • Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus

    Ethan Rubinstein;Marin H. Kollef;Dilip Nathwani

  • New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.

    George G. Zhanel;Divna Calic;Frank Schweizer;Sheryl Zelenitsky

  • The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).

    Stuart A. Dickerman;Elias Abrutyn;Bruno Barsic;Emilio Bouza

  • Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children.

    Gili Regev-Yochay;Ron Dagan;Meir Raz;Yehuda Carmeli

  • Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings.

    Gili Regev-Yochay;Gili Regev-Yochay;Meir Raz;Ron Dagan;Nurith Porat

  • Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli

    George G. Zhanel;George G. Zhanel;Phillip Chung;Heather Adam;Heather Adam;Sheryl Zelenitsky

  • An Outbreak of Phialemonium Infective Endocarditis Linked to Intracavernous Penile Injections for the Treatment of Impotence

    Jacob Strahilevitz;Galia Rahav;Hans Josef Schroers;Richard C. Summerbell

  • Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence

    P. Ball;F. Baquero;O. Cars;T. File

  • Non-HACEK gram-negative bacillus endocarditis.

    Susan Morpeth;David Murdoch;Christopher H. Cabell;Adolf W. Karchmer

  • Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

    Ethan Rubinstein;Tahaniyat Lalani;G. Ralph Corey;Zeina A. Kanafani

  • Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults.

    Katherine A. Hendricks;Mary E. Wright;Sean V. Shadomy;John S. Bradley

  • West Nile fever outbreak, Israel, 2000: epidemiologic aspects.

    Weinberger M;Pitlik Sd;Gandacu D;Lang R

  • Cefepime versus Imipenem-Cilastatin for Treatment of Nosocomial Pneumonia in Intensive Care Unit Patients: a Multicenter, Evaluator-Blind, Prospective, Randomized Study

    G. Zanetti;F. Bally;G. Greub;J. Garbino

  • Candida infective endocarditis

    John W. Baddley;John W. Baddley;Daniel K. Benjamin;Mukesh Patel;Mukesh Patel;José Miró

  • The consensus group on resistance and prescribing in respiratory tract infection. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

    P. Ball;F. Baquero;O. Cars;T. File

Frequent Co-Authors

George G. Zhanel
George G. Zhanel University of Manitoba
James A. Karlowsky
James A. Karlowsky University of Manitoba
G. Ralph Corey
G. Ralph Corey Duke University
Daryl J. Hoban
Daryl J. Hoban University of Manitoba
Heather J. Adam
Heather J. Adam University of Manitoba
Philippe R. S. Lagacé-Wiens
Philippe R. S. Lagacé-Wiens University of Manitoba
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Andrew Walkty
Andrew Walkty University of Manitoba
Vance G. Fowler
Vance G. Fowler Duke University
José M. Miró
José M. Miró University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can expand career options in the healthcare and information management sectors. One promising path is health information management, where professionals handle critical medical data. To enter this field, pursuing an online cahiim accredited health information management degree ensures the credential meets industry standards and boosts employability.

Career prospects in this area are encouraging, with reports on health information management salary showing competitive earnings and steady growth. For those seeking faster entry, an accredited fast medical billing and coding certificate online offers a streamlined pathway to essential roles in medical record processing and billing.

Additionally, the variety of online healthcare degrees available today allows microbiology graduates to specialize further or shift into complementary health professions. Overall, combining microbiology knowledge with health information skills opens diverse and rewarding career pathways in the evolving healthcare landscape.

Best Scientists Citing Ethan Rubinstein

Recently Published Articles